May 2021

19% of heart attack survivors develop heart failure within 5 years
Interventional cardiologists back prior authorization bill, call current policies ‘costly' and ‘time consuming’
Landmark discovery provides clinicians with a ‘valuable clinical tool’ for diagnosing myocarditis
Cardiac arrest numbers highlight the pandemic’s long-term impact on patient care
Dapagliflozin a cost-effective treatment for HFrEF at its current price point
Cancer patients after PCI: Key statistics every cardiologist should know
Cardiologist shares a warning fish oil can no longer be considered harmless
13% of TAVR patients develop acute kidney injury, increasing their risk of in-hospital mortality
Eating plant-based meals late in the day lowers risk of cardiovascular disease by 10%
New AI model uses readily available healthcare data to predict type 2 diabetes
Radial access outperforms femoral access for complex PCI, but questions persist
Digital health specialists gain 2 new FDA clearances for cardiac care portfolio
DASH diet, developed to lower blood pressure, provides additional cardiovascular benefits
Cardiovascular Subspecialty Clinics: How to Grow Big by Thinking Small
A Physician’s Perspective: Atherectomy to Help Address the Challenges of Complex Care
How the recovery of young heart attack survivors is impacted by the world around them
STEMI following TAVR associated with high rates of mortality, PCI failure
CDC reviewing cases of heart damage in young adults after COVID-19 vaccination
FDA announces recall of more than 30,000 Boston Scientific stent systems after numerous injuries
Marijuana use linked to a greater risk of heart damage
Aggressive blood pressure management associated with a lower risk of heart attack, heart failure, death from CVD
Abbott’s TriClip a safe, effective treatment option for severe tricuspid regurgitation
New York cardiologist sentenced to 20 months in prison, fined $100K for elaborate fraud scheme
Stress and anxiety from U.S. presidential election led to a 77% increase in heart rhythm issues
CVD deaths are down across the US, but many counties continue to struggle
TAVR or surgery? Cardiologists say better communication would boost care for patients with structural heart disease
It’s official: Heart Rhythm 2021 is happening with no capacity restrictions
Cardiac MRI a ‘powerful’ tool for assessing, predicting pulmonary arterial hypertension
Virginia health system sues competitor for $20M for allegedly blocking expansion, hiring away cardiologists
LAAO with Watchman device consistently lowers stroke risk after 1 year
When STEMI patients present late, immediate and delayed PCI lead to similar outcomes
Apixaban appears safe for most TAVR patients, but questions remain
Elective revascularization with PCI or CABG provides long-term cardiovascular benefits, new meta-analysis confirms
Dapagliflozin fails to reduce the risk of organ failure or death among COVID-19 patients
A milestone for Medtronic: Low-risk TAVR patients treated with Evolut ‘doing exceptionally well’ after 2 years
Abbott’s new self-expanding TAVR system gains CE mark approval
Finerenone limits AFib in patients with chronic kidney disease, Type 2 diabetes
Alcohol—even just one drink—increases the risk of AFib
The greatest benefit: Omecamtiv mecarbil improves outcomes the most for patients with severe heart failure
LAAO significantly lowers the risk of stroke after surgery among heart rhythm patients
Cardiologist salaries in the wake of COVID: 8 key takeaways from a new analysis
FDA announces recall of more than 60,000 Abbott pacemakers due to risk of electrical short
Cardiologists support bipartisan prior authorization bill, praising its ‘transparency’ and ‘oversight’
Significant MR after TAVR linked to higher mortality rates—but staged interventions may help
FDA advisory: Magnets in cell phones, smart watches can affect implanted medical devices
Young heart attack survivors who battle depression, anxiety more likely to have subsequent CV complications
High blood pressure linked to greater risk of heart failure, AFib, heart attack, stroke
FDA announces new recall of instructions for Medtronic’s HVAD system after 1 death, 64 injuries
TEER associated with an added benefit for SMR patients in earlier stages of heart failure
Boston-based tech company raises $8M to develop AI-powered CVD software
Unnecessary care? 1 in 3 patients with advanced dementia and AFib still given anticoagulants
Antidepressants, other common medications linked to high blood pressure
‘No better time than now’: ACC, AHA share new guidance on ethics and professionalism in cardiovascular care
Cardiologist leaves Amazon leadership role to join digital health startup
BASILICIA before TAVR is safe and effective, new data confirms
44% of cardiologists around the world have experienced a hostile work environment
AI model helps clinicians predict post-TAVR infective endocarditis
COVID-19 patients with mild symptoms make a full recovery with no lingering heart issues
CTA, ACC announce new plan to help device manufacturers connect with cardiologists
Family of singer Chris Cornell settles malpractice lawsuit with cardiologist
11% of TAVR sites deliver below-average care, suggesting a ‘meaningful performance gap’
COVID-19 may do long-term damage to the heart and blood vessels of young adults
Fish oil supplements linked to potentially fatal heart rhythm issues
Moderate alcohol consumption may lower risk of death from CVD
Considering vitamin supplements to prevent heart disease or cancer? Not so fast, USPSTF warns
1 in 10 patients with post-TAVR infective endocarditis have a stroke, increasing risk of death by 90%
Abbott launches new clinical trial focused on treating AFib, heart failure at the same time
Exposure to secondhand smoke leads to a 35% higher risk of heart failure
Children face long-term hypertension risk after surgery for congenital heart disease
Smile for the camera: Cardiologists around the world performing live procedures for charity
How valve type and anesthesia strategy affect 1-year TAVR outcomes
Heart failure patients face a substantial risk of pneumonia
A closer look at how subtle changes in the heart can lead to arrhythmias, death
FDA approves dapagliflozin for chronic kidney disease
Risk of a permanent pacemaker after valve-in-valve TAVR is low, especially when using newer heart valves
Processed meats, energy drinks, coconut oil and 5 other popular foods that can damage the heart
SCAI 2021: Medtronic pleased with 30-day data on Evolut TAVR systems
Low-value care, including CVD screening for low-risk adults, costs Medicare providers $478M per year
When TEER fails, most patients require mitral valve replacement